Lessons learned from option B+ in the evolution toward test and start from Malawi, Cameroon, and the United Republic of Tanzania

Journal of Acquired Immune Deficiency Syndromes

Volumn 75, Issue , 2017, Pages S43-S50

  Kalua, Thokozani ^a   Barr, Beth A Tippett ^b   Van Oosterhout, Joep J ^a,c   Mbori Ngacha, Dorothy ^d   Schouten, Erik J ^e   Gupta, Sundeep ^b   Sande, Amakobe ^f   Zomba, Gerald ^g   Tweya, Hannock ^h,i   Lungu, Edgar ^e,f   Kajoka, Deborah ^j   Tih, Pius ^k   Jahn, Andreas ^a,l  

^a UNIVERSITY OF MALAWI   (Malawi)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c DIGNITAS INTERNATIONAL   (Malawi)

^d UNICEF   (United States)

^e Management Sciences for Health   (Malawi)

^f Joint United Nations Programme on HIV AIDS (UNAIDS)   (Malawi)

^g UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^h LIGHTHOUSE TRUST   (Malawi)

ⁱ INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^j and Children   (Tanzania)

^k Cameroon Baptist Convention Health Services   (Cameroon)

^l UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

HIV AIDS; Option B+; Prevention of mother to child transmission; Scaling up of services

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIRETROVIRAL THERAPY; ARTICLE; CAMEROON; CONSENSUS DEVELOPMENT; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALAWI; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; TREATMENT PLANNING; VERTICAL TRANSMISSION; WORLD HEALTH ORGANIZATION; COMMUNICABLE DISEASE CONTROL; FEMALE; INFANT; NEWBORN; PREGNANCY; PREVENTION AND CONTROL; PROCEDURES; TANZANIA;

ANTI-RETROVIRAL AGENTS; CAMEROON; COMMUNICABLE DISEASE CONTROL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALAWI; PREGNANCY; TANZANIA;

EID: 85018756472     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000001326     Document Type: Article

References (13)

1. Estimating National HIV Prevalence in Malawi From Sentinel Surveillance Data: Technical Report. Lilongwe, Africa: National AIDS Commission; 2003.
2. van Oosterhout J, Bodasing N, Kumwanda J, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health. 2005;10:464-470.
3. Malawi HIV and AIDS Monitoring and Evaluation Report. Lilongwe, Africa: Malawi National AIDS Commission; 2008.
4. Malawi Ministry of Health Quarterly HIV Programme Report: January-March 2010. Lilongwe, Africa: Malawi Ministry of Health; 2010.
5. Schouten E, Jahn A, Midiani D, et al. Prevention of mother-to-child transmission of HIV and the health-related millenium development goals: time for a public health approach. Lancet. 2011;378: 282-284.
6. van Lettow M, Bedell R, Landes M, et al. Update and outcomes of a prevention-of-mother-to-child (PMTCT) program in Zomba District, Malawi. BMC Public Health. 2011;11:426.
7. Landes M, van Lettow M, Chan A, et al. Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi. PLoS One. 2012;7:e47337.
8. Rapid Advice: Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Geneva, Switzerland: World Health Organization; 2009.
9. Malawi Ministry of Health Integrated HIV Program Report July-September 2015. Lilongwe, Africa: Malawi Ministry of Health; 2015.
10. National HIV Transmission in 4-12 Week Olds in Malawi's PMTCT Option B+ Program. Conference on Retroviruses and Opportunistic Infections (CROI); 2016; Boston.
11. Tweya H, Gugsa S, Hosseinipour M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ programme in Lilongwe, Malawi. Trop Med Int Health. 2014;19:1360-1366.
12. Integrated HIV Program Report April-June 2012. Lilongwe, Africa: Malawi Ministry of Health; 2012.
13. Integrated HIV Program Report July-September 2015. Lilongwe, Africa: Malawi Ministry of Health; 2015.